Ovid Therapeutics, Inc. (OVID)
2.80
-0.13
(-4.44%)
USD |
NASDAQ |
Aug 28, 16:00
2.77
-0.03
(-1.07%)
After-Hours: 04:22
Ovid Therapeutics 1 Year Total Returns (Daily) : 124.0% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 124.0% |
| August 27, 2026 | 132.5% |
| August 26, 2026 | 136.1% |
| August 25, 2026 | 155.3% |
| August 24, 2026 | 173.8% |
| August 21, 2026 | 192.6% |
| August 20, 2026 | 188.4% |
| August 19, 2026 | 211.7% |
| August 18, 2026 | 204.5% |
| August 17, 2026 | 197.9% |
| August 14, 2026 | 236.8% |
| August 13, 2026 | 226.3% |
| August 12, 2026 | 379.0% |
| August 11, 2026 | 364.3% |
| August 10, 2026 | 408.8% |
| August 07, 2026 | 414.2% |
| August 06, 2026 | 419.4% |
| August 05, 2026 | 427.9% |
| August 04, 2026 | 411.6% |
| August 03, 2026 | 366.0% |
| July 31, 2026 | 344.0% |
| July 30, 2026 | 374.0% |
| July 29, 2026 | 323.8% |
| July 28, 2026 | 347.4% |
| July 27, 2026 | 280.0% |
| Date | Value |
|---|---|
| July 24, 2026 | 236.2% |
| July 23, 2026 | 242.9% |
| July 22, 2026 | 255.8% |
| July 21, 2026 | 298.1% |
| July 20, 2026 | 319.1% |
| July 17, 2026 | 409.1% |
| July 16, 2026 | 528.2% |
| July 15, 2026 | 576.6% |
| July 14, 2026 | 519.8% |
| July 13, 2026 | 500.0% |
| July 10, 2026 | 501.4% |
| July 09, 2026 | 494.4% |
| July 08, 2026 | 534.9% |
| July 07, 2026 | 638.0% |
| July 06, 2026 | 671.3% |
| July 02, 2026 | 713.9% |
| July 01, 2026 | 748.1% |
| June 30, 2026 | 715.4% |
| June 29, 2026 | 800.7% |
| June 26, 2026 | 643.4% |
| June 25, 2026 | 669.5% |
| June 24, 2026 | 728.6% |
| June 23, 2026 | 700.0% |
| June 22, 2026 | 624.9% |
| June 18, 2026 | 667.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 10.98% |
| Alnylam Pharmaceuticals, Inc. | -47.58% |
| Anika Therapeutics, Inc. | 128.6% |
| Savara, Inc. | 60.86% |
| Vericel Corp. | 14.10% |